Dec 9, 2024 · A systematic review and meta-analysis comparing outcomes between using subcutaneous insulin and continuous insulin infusion in managing adult patients with diabetic …

Feb 3, 2025 · The treatment of DKA in adults will be reviewed here. The epidemiology, pathogenesis, clinical features, evaluation, and diagnosis of DKA and HHS are discussed separately, as is the …

Sep 30, 2025 · These criteria aren't necessarily required for the clinical diagnosis and management of patients who clearly have DKA (i.e., a beta-hydroxybutyrate level is not needed for patients who …

Euglycemic DKA has now been seen in the setting of SGLT-2 inhibitors. Corrected sodium = measured sodium + 2.4 x (plasma glucose – 100)/100. Anion gap = Na – (Cl + HCO3) (use measured Na level). …

There are several important steps that should be followed in early management: Fluid therapy should be started immediately after initial laboratory evaluations.

• Educate all people with type 1 diabetes on the recognition, prevention, and treatment of DKA. • Provide guidance on frequent glucose monitoring and appropriate insulin therapy for times of fasting and …

patient guidelines These guidelines have been developed to advise the treatment and management of diabetic keto. cidosis in adults. The guideline recommendations have been developed and reviewed …

Jun 22, 2024 · The objective of this consensus report is to provide up-to-date knowledge about the epidemiology, pathophysiology, clinical presentation, and recommendations for the diagnosis, …

Jun 12, 2025 · Glycemic management — Target glycated hemoglobin (A1C) levels in patients with type 2 diabetes should be tailored to the individual, balancing the anticipated reduction in microvascular …

Diabetic ketoacidosis and hyperosmolar hyperglycemic state should be suspected in people who have diabetes and are ill. If either diabetic ketoacidosis or hyperosmolar hyperglycemic state is diagnosed, …